General Dermatology

Dermatology Times is recapping our exclusive expert interviews from the month of June.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Discover Hershel Dobkin's unique blend of humor and dermatology, offering insights that combat clinical burnout and bring joy to medical practice.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the FDA approval of dupilumab for bullous pemphigoid, the upcoming INTEGUMENT-INFANT trial for roflumilast, nail trends that challenge clinical diagnosis, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dupilumab gains FDA approval as the first targeted therapy for bullous pemphigoid, offering hope for effective treatment and improved patient outcomes.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Upadacitinib’s targeted inhibition of JAK1 offers a novel strategy for managing bullous pemphigoid and, in rare, treatment-resistant cases, may induce sustained remission following immune modulation.

Researchers conducted a systematic review to summarize research that has addressed social media’s impact on skin health promotion activities.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

LGBTQ+-inclusive language in dermatology enhances patient care, addresses health barriers, and improves outcomes for transgender individuals facing acne challenges.

This review of the latest dermatologic studies includes insights into differences in vitamin D levels in rosacea versus healthy individuals, psychosocial determinants and atopic dermatitis outcomes, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about abrocitinib's flexible dosing for atopic dermatitis, plant-derived exosomes in regenerative skin care, psychosocial support in hidradenitis suppurativa care, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

In celebration of Men's Health Month, Hershel Dobkin, MD, FAAD, shed some light on a "taboo" topic.

Alys plans to conduct a phase 1/1b trial assessing the efficacy and safety of the mast cell selective c-Kit inhibitor in the CIndU subtype.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This review of the latest dermatologic studies includes insights into skin improvement with injectable hyaluronic acid, burden of chronic spontaneous urticaria, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Almirall is pioneering a holistic approach in dermatology, emphasizing psychological well-being through the WHO-5 index in clinical trials.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.